Medications starting with
Spain-
It is used as an aid to stop smoking and to relieve the symptoms of nicotine withdrawal syndrome.
Dosage form: patches, transdermal
Active substance Dosage nicotine 17,5 mg Manufacturer: Dr. Reddy'S Netherlands B.V.
-
It is used as an aid to stop smoking, serving to relieve the symptoms of nicotine withdrawal syndrome.
Dosage form: chewing gum, medicinal
Active substance Dosage nicotine 2 mg Manufacturer: Dr. Reddy'S Netherlands B.V.
-
It is used as an aid to stop smoking, serving to relieve the symptoms of nicotine withdrawal syndrome.
Dosage form: chewing gum, medicinal
Active substance Dosage nicotine 4 mg Manufacturer: Dr. Reddy'S Netherlands B.V.
-
It is used as an aid to stop smoking and to relieve the symptoms of nicotine withdrawal syndrome.
Dosage form: chewing gum, medicinal
Active substance Dosage nicotine 2 mg Manufacturer: Dr. Reddy'S Netherlands B.V.
-
It is used as an aid to stop smoking, serving to relieve the symptoms of nicotine withdrawal syndrome.
Dosage form: chewing gum, medicinal
Active substance Dosage nicotine 4 mg Manufacturer: Dr. Reddy'S Netherlands B.V.
-
It is used to help adults over 18 years of age quit smoking by relieving the withdrawal symptoms and anxiety that occur when quitting tobacco or reducing consumption.
Dosage form: lozenges, for sucking
Active substance Dosage nicotine 1 mg Manufacturer: Dr. Reddy'S Netherlands B.V.
-
It is used to help adults over 18 years of age to stop smoking by relieving withdrawal symptoms and the anxiety that occurs when quitting or reducing tobacco consumption.
Dosage form: lozenges, for sucking
Active substance Dosage nicotine bitartrate dihydrate 6,144 mg Manufacturer: Dr. Reddy'S Netherlands B.V.
-
It is used to treat central diabetes insipidus (a condition that causes excessive thirst and large amounts of diluted urine) and enuresis (involuntary urination during the night) in patients over 5 years of age who are able to concentrate their urine.
Dosage form: solution, oral
Active substance Dosage desmopressin acetate 6.0 mg Manufacturer: Gp Pharm S.A.
-
It is used to delay imminent preterm labor in pregnant women presenting with regular contractions and cervical dilation between 24 and 33 weeks of gestation, provided the baby's heart rate is normal.
Dosage form: solution, oral
Active substance Dosage nifedipine 5 mg Manufacturer: Laboratorio Reig Jofre, S.A.
-
It is used to treat chronic inflammatory rheumatism and osteoarthritis in adults and children over 12 years of age. It is also used for short-term pain due to acute osteoarthritis, joint inflammation (such as tendinitis or bursitis), and pain due to inflammation of the throat, ears, or mouth.
Dosage form: capsules, hard
Active substance Dosage niflumic acid 250 mg Manufacturer: Upsa S.A.S.
-
It is used to reduce 'bad' cholesterol (LDL cholesterol) levels in the blood in adults with primary hypercholesterolemia or mixed dyslipidemia, or in adults with elevated cholesterol levels who already have cardiovascular disease or are at risk of cardiovascular events. It is used when statins are insufficient or cannot be used.
Dosage form: tablets, film-coated
Active substance Dosage bempedoic acid 180 mg Manufacturer: Daiichi Sankyo Europe Gmbh
-
It is used to treat a type of blood cancer called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adults and children, either upon new diagnosis or when other treatments have not worked or have caused serious side effects.
Dosage form: capsules, hard
Active substance Dosage nilotinib 150 mg Manufacturer: Accord Healthcare S.L.U.
-
It is used to treat a type of blood cancer called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adults and children, either as a first-line treatment or when other medicines have not worked or have caused serious side effects.
Dosage form: capsules, hard
Active substance Dosage nilotinib 200 mg Manufacturer: Accord Healthcare S.L.U.
-
It is used to treat a type of blood cancer called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adults and children, either as a new diagnosis or when other treatments have not worked or have caused serious side effects.
Dosage form: capsules, hard
Active substance Dosage nilotinib 50 mg Manufacturer: Accord Healthcare S.L.U.
-
It is used to treat a type of blood cancer called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adults and children.
Dosage form: capsules, hard
Active substance Dosage nilotinib hydrochloride dihydrate 170,54 mg Manufacturer: Laboratorio Stada S.L.
-
It is used to treat a type of blood cancer called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adults and children.
Dosage form: capsules, hard
Active substance Dosage nilotinib hydrochloride dihydrate 227,38 mg Manufacturer: Laboratorio Stada S.L.
-
It is used to treat a type of blood cancer called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adults and children, either as a new diagnosis or when other treatments have not worked or have caused serious side effects.
Dosage form: capsules, hard
Active substance Dosage nilotinib hydrochloride dihydrate 170,54 mg Manufacturer: Teva Gmbh
-
It is used to treat a type of blood cancer called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adults and children, either as a new diagnosis or when previous treatments have not worked or have caused serious side effects.
Dosage form: capsules, hard
Active substance Dosage nilotinib hydrochloride dihydrate 227,38 mg Manufacturer: Teva Gmbh
-
It is used to treat a type of blood cancer called Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adults and children, either in newly diagnosed patients or in those who have not responded to previous treatments.
Dosage form: capsules, hard
Active substance Dosage nilotinib 200 mg Manufacturer: Zentiva K.S.
-
It is a vaccine that helps protect against infections caused by the Neisseria meningitidis bacteria of types A, C, W-135, and Y, which can cause serious diseases such as meningitis or septicemia.
Dosage form: powder and solvent for solution for injection
Active substance Dosage meningococcal polysaccharide antigen group a 5 µg meningococcal group c polysaccharide antigen 5 µg meningococcal polysaccharide antigen group w-135 5 µg meningococcal polysaccharide antigen group y 5 µg Manufacturer: Pfizer Europe Ma Eeig
-
It is a vaccine that helps protect against infections caused by Neisseria meningitidis bacteria of types A, C, W-135, and Y, which can cause serious diseases such as meningitis or septicemia.
Dosage form: powder and solvent for solution for injection
Active substance Dosage meningococcal polysaccharide antigen group a 5 µg meningococcal group c polysaccharide antigen 5 µg meningococcal polysaccharide antigen group w-135 5 µg meningococcal polysaccharide antigen group y 5 µg Manufacturer: Pfizer Europe Ma Eeig
-
It is used to prevent neurological deterioration caused by cerebral vasospasm resulting from a subarachnoid hemorrhage (a type of brain hemorrhage caused by a ruptured aneurysm).
Dosage form: solution for infusion
Active substance Dosage nimodipine 10 mg Manufacturer: Altan Pharmaceuticals Sa
-
It is used to prevent neurological damage caused by a lack of blood supply due to the constriction of cerebral arteries following a brain bleed (subarachnoid hemorrhage).
Dosage form: tablets, film-coated
Active substance Dosage nimodipine 30 mg Manufacturer: Laboratorio Stada S.L.
-
It is used to prevent neurological deterioration caused by cerebral vasospasm resulting from subarachnoid hemorrhage (a type of brain hemorrhage caused by a ruptured aneurysm).
Dosage form: solution for infusion
Active substance Dosage nimodipine 10 mg Manufacturer: Laboratoire X.O
-
It is used to treat adult patients with Alzheimer's dementia (mild to moderately severe) and also for dementia associated with Parkinson's disease.
Dosage form: capsules, hard
Active substance Dosage rivastigmine hydrogen tartrate 2.40 mg Manufacturer: Krka D.D. Novo Mesto
-
It is used to treat adult patients with Alzheimer's dementia (mild to moderately severe) and dementia associated with Parkinson's disease.
Dosage form: capsules, hard
Active substance Dosage rivastigmine hydrogen tartrate 4,80 mg Manufacturer: Krka D.D. Novo Mesto
-
It is used to treat adult patients with Alzheimer's dementia (mild to moderately severe) and dementia associated with Parkinson's disease.
Dosage form: capsules, hard
Active substance Dosage rivastigmine hydrogen tartrate 7,20 mg Manufacturer: Krka D.D. Novo Mesto
-
It is used to treat adult patients with Alzheimer's dementia (mild to moderately severe) and also to treat dementia in adult patients with Parkinson's disease.
Dosage form: capsules, hard
Active substance Dosage rivastigmine hydrogen tartrate 7.20 mg Manufacturer: Krka D.D. Novo Mesto
-
It is used to treat adult patients with Alzheimer's dementia (mild to moderately severe) and for dementia associated with Parkinson's disease.
Dosage form: capsules, hard
Active substance Dosage rivastigmine hydrogen tartrate 9,60 mg Manufacturer: Krka D.D. Novo Mesto
-
It is used to treat adult patients with Alzheimer's dementia (mild to moderately severe) and also for dementia associated with Parkinson's disease.
Dosage form: capsules, hard
Active substance Dosage rivastigmine hydrogen tartrate 9,60 mg Manufacturer: Krka D.D. Novo Mesto
-
It is used to achieve a rapid onset and resolution of analgesic effect for mild to moderate pain of limited duration.
Dosage form: gas, medicinal compressed
Active substance Dosage nitrous oxide 269.76 g oxygen 196.14 g Manufacturer: Nippon Gases Espana Slu
-
It is used to treat idiopathic pulmonary fibrosis (IPF) in adults, other chronic fibrosing interstitial lung diseases (ILD) with a progressive phenotype in adults, progressive fibrosing interstitial lung diseases (ILD) in children and adolescents between 6 and 17 years of age, and systemic sclerosis-associated interstitial lung disease (SSc-ILD) in adults, adolescents, and children aged 6 years or older.
Dosage form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 120,40 mg Manufacturer: Accord Healthcare S.L.U.
-
It is used to treat idiopathic pulmonary fibrosis (IPF) in adults, other chronic fibrosing interstitial lung diseases (ILD) with a progressive phenotype in adults, progressive fibrosing interstitial lung diseases in children and adolescents aged 6 to 17 years, and systemic sclerosis-associated interstitial lung disease in adults, adolescents, and children aged 6 years or older.
Dosage form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 180,60 mg Manufacturer: Accord Healthcare S.L.U.
-
It is used in combination with another medicine (docetaxel) to treat a type of non-small cell lung cancer called adenocarcinoma in adults, when the tumor has grown again after having received another treatment.
Dosage form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 120,4 mg Manufacturer: Accord Healthcare S.L.U.
-
It is used in combination with another medication (docetaxel) to treat a type of lung cancer called non-small cell lung cancer (adenocarcinoma) in adults, when the tumor has grown again after previous treatment.
Dosage form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 180,6 mg Manufacturer: Accord Healthcare S.L.U.
-
It is used to treat idiopathic pulmonary fibrosis (IPF) in adults, other chronic fibrosing interstitial lung diseases (ILD) with a progressive phenotype in adults, progressive fibrosing interstitial lung diseases in children and adolescents between 6 and 17 years of age, and systemic sclerosis-associated interstitial lung disease (SSc-ILD) in adults, adolescents, and children aged 6 years or older.
Dosage form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 120,41 mg Manufacturer: Laboratorios Cinfa S.A.
-
It is used to treat idiopathic pulmonary fibrosis (IPF) in adults, other chronic fibrosing interstitial lung diseases (ILD) with a progressive phenotype in adults, progressive fibrosing interstitial lung diseases in children and adolescents aged 6 to 17 years, and systemic sclerosis-associated interstitial lung disease in adults, adolescents, and children aged 6 years or older. It helps reduce the onset of further scarring and hardening of the lungs.
Dosage form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 180,61 mg Manufacturer: Laboratorios Cinfa S.A.
-
It is used to treat idiopathic pulmonary fibrosis (IPF), other chronic fibrosing interstitial lung diseases (ILD), systemic sclerosis-associated interstitial lung disease (SSc-ILD) in adults and children aged 6 years and older, and non-small cell lung cancer (NSCLC) in adults.
Dosage form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 120,4 mg Manufacturer: Reddy Pharma Iberia S.A.
-
It is used to treat idiopathic pulmonary fibrosis (IPF), other chronic fibrosing interstitial lung diseases (ILD), and systemic sclerosis-associated interstitial lung disease in adults and children aged 6 years and older. It is also used to treat a specific type of non-small cell lung cancer (NSCLC) in adults, in combination with another medication.
Dosage form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 180,60 mg Manufacturer: Reddy Pharma Iberia S.A.
-
It is used to treat idiopathic pulmonary fibrosis (IPF) in adults, other chronic fibrosing interstitial lung diseases (ILD) with a progressive phenotype in adults, progressive fibrosing interstitial lung diseases in children and adolescents aged 6 to 17 years, and systemic sclerosis-associated interstitial lung disease in adults, adolescents, and children aged 6 years or older.
Dosage form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 120,4 mg Manufacturer: Eugia Pharma (Malta) Limited
-
It is used to treat idiopathic pulmonary fibrosis (IPF) in adults, other chronic fibrosing interstitial lung diseases (ILD) with a progressive phenotype in adults, progressive fibrosing interstitial lung diseases in children and adolescents between 6 and 17 years of age, and systemic sclerosis-associated interstitial lung disease (SSc-ILD) in adults, adolescents, and children aged 6 years and older.
Dosage form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 180,6 mg Manufacturer: Eugia Pharma (Malta) Limited
-
It is used in adults to treat idiopathic pulmonary fibrosis (IPF), other chronic fibrosing interstitial lung diseases (ILD) with a progressive phenotype, and systemic sclerosis-associated interstitial lung disease (SSc-ILD). It helps to reduce the onset of new scarring and stiffening of the lungs.
Dosage form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 120,4 mg Manufacturer: Laboratorio Stada S.L.
-
It is used in adults to treat idiopathic pulmonary fibrosis (IPF), other chronic fibrosing interstitial lung diseases (ILD) with a progressive phenotype, and systemic sclerosis-associated interstitial lung disease (SSc-ILD). It helps reduce the onset of new scarring and stiffening of the lungs.
Dosage form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 180,6 mg Manufacturer: Laboratorio Stada S.L.
-
It is used in adults to treat idiopathic pulmonary fibrosis (IPF), other chronic fibrosing interstitial lung diseases (ILD) with a progressive phenotype, and systemic sclerosis-associated interstitial lung disease (SSc-ILD).
Dosage form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 120,4 mg Manufacturer: Teva Pharma S.L.U.
-
It is used in adults to treat idiopathic pulmonary fibrosis (IPF), other chronic fibrosing interstitial lung diseases (ILD) with a progressive phenotype, and systemic sclerosis-associated interstitial lung disease (SSc-ILD).
Dosage form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 180,6 mg Manufacturer: Teva Pharma S.L.U.
-
It is used to treat idiopathic pulmonary fibrosis (IPF) in adults, other chronic progressive fibrosing interstitial lung diseases (ILD) in adults, progressive fibrosing interstitial lung diseases in children and adolescents aged 6 to 17 years, and systemic sclerosis-associated interstitial lung disease in adults, adolescents, and children aged 6 years or older.
Dosage form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 120,40 mg Manufacturer: Viatris Limited
-
It is used to treat idiopathic pulmonary fibrosis (IPF) in adults, other chronic fibrosing interstitial lung diseases (ILD) with a progressive phenotype in adults, progressive fibrosing interstitial lung diseases in children and adolescents aged 6 to 17 years, and interstitial lung disease associated with systemic sclerosis in adults, adolescents, and children aged 6 years and older. It helps reduce the progression of lung scarring and stiffening.
Dosage form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 180,60 mg Manufacturer: Viatris Limited
-
It is used to treat idiopathic pulmonary fibrosis in adults, other chronic fibrosing interstitial lung diseases with a progressive phenotype, progressive fibrosing interstitial lung diseases in children and adolescents between 6 and 17 years of age, and interstitial lung disease associated with systemic sclerosis in adults, adolescents, and children aged 6 years or older.
Dosage form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 120,4 mg Manufacturer: Zentiva K.S.
-
It is used to treat idiopathic pulmonary fibrosis (IPF) in adults, other chronic fibrosing interstitial lung diseases (ILD) with a progressive phenotype in adults, progressive fibrosing interstitial lung diseases in children and adolescents between 6 and 17 years of age, and interstitial lung disease associated with systemic sclerosis in adults, adolescents, and children aged 6 years or older.
Dosage form: capsules, soft gelatin
Active substance Dosage nintedanib esilate 180,6 mg Manufacturer: Zentiva K.S.
-
It is used to treat adults with hairy cell leukemia, which is a type of cancer that affects lymphocytes (white blood cells).
Dosage form: powder for injectable solution and for perfusion
Active substance Dosage pentostatin 10,0 mg Manufacturer: Pfizer S.L.